- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-07-0008704

About Zexprim Pharmacls Private Limited
Data last updated:
Zexprim Pharmacls Private Limited is a private limited company based in Uttarpara, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74999WB2018PTC225704. Its GSTIN is 19AABCZ2040F1ZJ (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Partha Kumar Bandyopadhyay and Chinmoy Banerjee.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1st Floor Flat No. B – 1 25 Brb G.T. Road Bhadrakali., Uttarpara, West Bengal, India – 712232.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.92 Cr. For the same year it recorded a net profit of ₹12.14 Lakh (net margin 2.1%) and EBITDA of ₹53.52 Lakh (EBITDA margin 9%).
The company has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.2 Cr on record.
Zexprim Pharmacls Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-07-0008704). For more details, the company can be reached via its website zexprim.in.
Company details
Recognitions & Rankings of Zexprim Pharmacls
Contact details
Zexprim Pharmacls Private Limited's registered office is in Uttarpara, West Bengal. Its website is zexprim.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1st Floor Flat No. B – 1 25 Brb G.T. Road Bhadrakali., Uttarpara, West Bengal, India – 712232
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zexprim Pharmacls Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zexprim Pharmacls is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Zexprim Pharmacls Private Limited, buy the company report.
Financials of Zexprim Pharmacls Private Limited
FY 2024 filings availableZexprim Pharmacls Private Limited reported revenue of ₹5.92 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹53.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zexprim Pharmacls Private Limited, buy the company report.
Board of directors of Zexprim Pharmacls Private Limited
Zexprim Pharmacls has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Partha Kumar Bandyopadhyay | Director | 17 Apr 2018 | 8 Years 6 Months | Current |
| Chinmoy Banerjee | Director | 17 Apr 2018 | 8 Years 6 Months | Current |
Auditor
Zexprim Pharmacls Private Limited is audited by JHA PYNE & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JHA PYNE & ASSOCIATES | FY 2023 | 0331764E |
Shareholding
The shareholding of Zexprim Pharmacls Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zexprim Pharmacls Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Apr 2025 | 101083087 | Others | ₹2 Cr | Open | |
| 12 Feb 2021 | 100440154 | Others | ₹2.2 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Zexprim Pharmacls Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zexprim Pharmacls Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Zexprim Pharmacls Private Limited has a workforce of 11 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 11 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Zexprim Pharmacls Private Limited, buy the company report.
GST
Zexprim Pharmacls has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCZ2040F1ZJ | West Bengal | Active | 02 Jan 2019 |
To see the full GST registrations and return filing status of Zexprim Pharmacls Private Limited, buy the company report.
Recent activity
Zexprim Pharmacls Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Chinmoy Banerjee was appointed as Director on 17 Apr 2018.
Frequently asked questions
Zexprim Pharmacls is an active private limited company based in Uttarpara, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 April 2018 (8+ years old) and is registered under CIN U74999WB2018PTC225704.
Zexprim Pharmacls has 2 current directors:
- Partha Kumar Bandyopadhyay - Director
- Chinmoy Banerjee - Director
The latest financial statements of Zexprim Pharmacls on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Zexprim Pharmacls is 19AABCZ2040F1ZJ, registered in West Bengal.
The CIN (Corporate Identification Number) of Zexprim Pharmacls is U74999WB2018PTC225704. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zexprim Pharmacls was incorporated on 17 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kolkata.
Chinmoy Banerjee was appointed as Director on 17 Apr 2018. Partha Kumar Bandyopadhyay was appointed as Director on 17 Apr 2018.
Yes, Zexprim Pharmacls is registered as a small enterprise under Udyam registration (number: UDYAM-WB-07-0008704).
Zexprim Pharmacls can be reached through the website zexprim.in. Its registered office is in Uttarpara, West Bengal, India.
The registered office of Zexprim Pharmacls is at 1st Floor Flat No. B – 1 25 Brb G.T. Road Bhadrakali., Uttarpara, West Bengal, India – 712232.

